*
*
*
*
*
Top 
Course Schedule Preliminary Programme
Thursday, November 15th
8.30

Registration

9.30

Lecture 1

Biological evolution of molecular markers in breast cancer

10.00

Lecture 2

Clinical implications of biomarker changes

10.30

Lecture 3

Proliferative markers: prognostic and predictive role

11.00

Coffee break

 

11.30

Clinical case discussion 1

Biopsy of metastases in breast cancer patients

13.00

Lunch

 

14.00

Debate 1: How far can we go to minimize therapy of primary breast cancer?

Positive sentinel node: can we avoid axillary dissection?
- YES we can
- NO, except when...

 

Partial breast cancer irradiation:
- When could be done
- When should not be done

15.40

Coffee break

 

16.00

Lecture 4

Early Breast Cancer: systemic treatment. An update

16.40

Debate 2

Intensive follow up after primary curative therapy

18.00

Adjourn

 

Friday, November 16th
8.30

Lecture 5

Primary systemic therapy: biological and clinical end points

9.00

Lecture 6

Breast reconstruction and radiation therapy

9.30

Clinical case discussion 2

Management after primary systemic therapy

11.00

Coffee break

 

11.30

Lecture 7

Preservation of fertility and pregnancy after breast cancer

12.00

Lecture 8

Male breast cancer

12.30

Lunch

 

13.30

Lecture 9

Management of advanced breast cancer patients: how to translate scientific advances into daily practice

14.00

Lecture 10

Management of elderly breast cancer patient

14.30

Lecture 11

New bone targeting agents

15.00

Coffee break

 

15.30

Lecture 12

Clinical and ethical challenges in treatment decision

16.00

Ceremony for the presentation of the Award for advances in breast cancer research, the Monica Boscolo Research Grant and the Patrizia Rossi merit award.

 

16.30

Lecture of the awardee

 

18.00

Adjourn

 

Saturday, November 17th
8.30

Round Table - Not for CME credits

Challenges in drug development and accessibility. a view from different perspectives: scientists, clinicians, pharma representatives, regulatory officials, payers, patients, media representatives.


10.00

Lecture 13

Clinical genomics for personalized cancer medicine

10.30

Lecture 14

Immunotherapy for breast cancer: premises and promises

11.00

Coffee break

 

11.15

Highlights from ASCO, SABCS, EBCC

 

11.45

Round Table - Strategies to overcome resistance in BC molecular subtypes

- HR + disease
- HER2+ disease
- Triple negative

13.00

Adjourn and final evaluation questionnaire

 

Top 
Directors And Other Speakers
Speaker 1

Pier Franco Conte

Integrated Department of Oncology, Hematology and Respiratory Diseases

University Hospital of Modena
University of Modena-Reggio Emilia (I)

Scientific Committee

Alberto Amadori

Scientific Director
Istituto Oncologico Veneto
Padova (I)

Ermanno Ancona

Department of Surgery, Oncology and Gastroenterology
University of Padova (I)

Valentina Guarneri

Integrated Department of Oncology, Hematology and Respiratory Diseases
University Hospital of Modena
University of Modena and Reggio Emilia (I)

Fikri Içli

Oncology Research and Treatment Center
Ankara University (T)

Jacek Jassem

Department of Oncology and Radiotherapy Medical
University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Preliminary list of speakers

Giovanni Apolone

Reggio Emilia (I)

Franco Barbazza

Padova (I)

Adriana Bazzi

Milano (I)

Jonas Bergh

Stockholm (SW)

Jean-Pierre Bizzari

Summit – NJ (USA)

Fernando Bozza

Padova (I)

Pier Franco Conte

Modena (I)

Francesco De Lorenzo

Roma (I)

Lucia Del Mastro

Genova (I)

Ana Maria Gonzalez-Angulo

Houston (USA)

Valentina Guarneri

Modena (I)

Gabriel N. Hortobagyi

Houston, TX (USA)

Fikri Içli

Ankara (TR)

Jacek Jassem

Gdansk (PL)

Picture

Gabriel N. Hortobagyi

Department of Breast Medical Oncology

University of Texas - MD Anderson Cancer Center
Houston (USA)

 

David Khayat

Medical Oncology Department
Salpetriere Hospital
Paris (F)

Sibylle Loibl

German Breast Group
University
Frankfurt (D)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Maranon
Madrid (S)

Donato Nitti

Department of Surgery, Oncology and Gastroenterology
University of Padova (I)

Philip Poortmans

Department of Radiation Oncology
Dr. Verbeeten Instituut
Tilburg (NL)

Christoph Zielinski

Clinical Division of Oncology Medical
University - General Hospital
Vienna (A)

 

Stephen Johnston

London (UK)

David Khayat

Paris (F)

Sibylle Loibl

Frankfurt (D)

Miguel Martin

Madrid (S)

Roberto Orecchia

Milan (I)

Paolo Paoletti

Collegeville PA (USA)

Philip Poortmans

Tilburg (NL)

Paolo Pronzato

Genova (I)

Richard Theriault

Houston (USA)

Giuseppe Viale

Milan (I)

Vittorina Zagonel

Padova (I)

Giorgio Zavagno

Padova (I)

Christoph Zielinski

Vienna (A)

Top 

Advanced International Breast Cancer Course

Mortality from breast cancer is rapidly declining in most countries worldwide and nowadays breast cancer patients have a great chance for cure. These results are extraordinary if we remember that breast cancer is by and large the most frequent tumor among females and it is still considered one of the “big killers”. Now that we are so close to our objectives, we must maximize our efforts to provide a more personalized approach to the individual patient, to optimize the appropriate use of resources and to develop innovative therapies for the patients not yet cured.

With these goals in mind, the Programme of this international Conference includes lectures on the molecular characterization of primary and metastatic tumors, update management of early and advanced disease, strategies to overcome resistance to available therapies, innovative therapies, preservation of fertility and treatment of male breast cancer. Clinical case discussions and debates are also planned to discuss topics which require a multifaceted approach or are matter of controversy.

This 8th Breast Cancer Conference includes a highly qualified international faculty, but will maintain its characteristics of a friendly forum where international opinion leaders and attendees will exchange experiences and share the most exiting advances. In order to reward scientific excellence and to foster international cooperation, the International Scientific Committee of the 8th AIBCC will award the third international Prize for Breast Cancer research to a scientist who has published a breakthrough paper in the previous year and the Monica Boscolo research Grant to an italian scientist for a research project to be conducted in cooperation with a foreign institution.

The Local Organizing Committee will award the Patrizia Rossi prize to the best thesis on breast cancer from a graduate in medicine or postgraduate in medical oncology from Italian universities. We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere.


Awards

  • MONICA BOSCOLO RESEARCH GRANT

    The scientific Committee will select the winner of the Monica Boscolo Research Grant. This Research Award is restricted to young Italian researchers (< 40 years) who will carry out a research project at a foreign institution.

  • INTERNATIONAL PRIZE FOR BREAST CANCER RESEARCH

    The Scientific Committee will select a young researcher who has published, as principal author in an international peer-reviewed journal, a manuscript reporting important clinical or biological advances in breast cancer. the winner will be invited to present his/her study during the annual Conference.

  • PATRIZIA ROSSI MERIT AWARD

    This prize will be awarded to the best thesis on breast cancer from a graduate in medicine or postgraduate in medical oncology from Italian Universities.


Addressed to

Oncologists, radiologists, radiation oncologists, pathologists, surgeons.


Official Language

The official language of the meeting is English. No simultaneous translation will be provided.


ECM

Based on the in force regulations approved by the CNFC, Accademia Nazionale di Medicina (provider n. 31) will request the CME accreditation. The round table saturday, November 17th at 8.30 a.m. is not for CME Credits.

The meeting is addressed to physicians specialized in oncology, radiology, radiation oncology, pathology, surgery.

The credit certification is subject to:

  • attendance at the entire Meeting
  • the completion of the meeting evaluation form
  • the completion of the final questionnaire (at least 75% of correct answers)

We would like to remind to participants that only 1/3 of the CME Credits acquired during the years 2011-2013 can come from a sponsorship.

Top 
How to Attend General Information

Meeting venue:

Centro Congressi Padova A. Luciani
via Forcellini 170/a, Padova

How to reach the meeting venue

Registration

The registration fee is € 250,00 tax free. It includes the conference bag, the conference book and all coffee breaks and lunches. It does not include hotel accomodation, dinners and travel expenses.

To register, please send:

  • registration form duly filled out (even when sponsored by a Pharmaceutical Company). Click on the button below to fill it on line
  • payment receipt

to: Accademia Nazionale di Medicina, Palazzina CUP ii Piano, via Massarenti 9, 40138 Bologna (fax 0039.051.636.46.05 – email: info.bologna@accmed.org), within November, 2nd 2012.

By submitting the form and the payment, your registration is completed with the exception of specific decisions of the Meeting secretariat. Incomplete registration will NOT be admitted. The registration will be confirmed by e-mail

Cancellation

If the participants minimum number is not reached, Accademia Nazionale di Medicina will advise by a written communication and proceed with the total refund of the fee.
In order to cancel please give advise with a written communication to Accademia Nazionale di Medicina within 10 days from the beginning. A 70% of the registration fee will be returned. Any cancellation after that deadline will not be reimbursed.